Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview.
Roberta GualtierottiMarco ParisiFrancesca IngegnoliPublished in: Advances in therapy (2018)
Patients with inflammatory rheumatic diseases often need orthopaedic surgery due to joint involvement. Total hip replacement and total knee replacement are frequent surgical procedures in these patients. Due to the complexity of the inflammatory rheumatic diseases, the perioperative management of these patients must envisage a multidisciplinary approach. The frequent association with extraarticular comorbidities must be considered when evaluating perioperative risk of the patient and should guide the clinician in the decision-making process. However, guidelines of different medical societies may vary and are sometimes contradictory. Orthopaedics should collaborate with rheumatologists, anaesthesiologists and, when needed, cardiologists and haematologists with the common aim of minimising perioperative risk in patients with inflammatory rheumatic diseases. The aim of this review is to provide the reader with simple practical recommendations regarding perioperative management of drugs such as disease-modifying anti-rheumatic drugs, corticosteroids, non-steroidal anti-inflammatory drugs and tools for a risk stratification for cardiovascular and thromboembolic risk based on current evidence for patients with inflammatory rheumatic diseases.
Keyphrases
- end stage renal disease
- cardiac surgery
- patients undergoing
- oxidative stress
- ejection fraction
- total hip
- total knee arthroplasty
- chronic kidney disease
- newly diagnosed
- minimally invasive
- anti inflammatory drugs
- decision making
- healthcare
- peritoneal dialysis
- prognostic factors
- rheumatoid arthritis
- acute kidney injury
- clinical practice
- case report
- atrial fibrillation
- quality improvement
- patient reported outcomes
- coronary artery disease